Hively Brad 4
4 · Oncology Institute, Inc. · Filed Dec 2, 2024
Insider Transaction Report
Form 4
Hively Brad
Director
Transactions
- Other
Common stock
2024-11-12−353,450→ 366,753 total - Purchase
Common stock
2024-11-26$0.17/sh+250,000$42,500→ 616,753 total - Purchase
Common stock
2024-12-02$0.15/sh+50,000$7,500→ 666,753 total
Footnotes (2)
- [F1]Reflects the forfeiture of restricted earn-out shares that were unvested due to failure to meet earnout targets of the Issuer's stock price of $12.50 and $15.00 per share for 20 days within any 30 consecutive trading days for the three-year period following November 12, 2021, the date of the closing of the Business Combination, subject to continued employment at such time.
- [F2]44,000 being restricted stock units that vest in full on the date of the Company's 2025 annual meeting of stockholders, subject to continued service with the Company through such vesting date.